Breast Cancer Diagnoses in Maryland in 2023: What These RCCA Experts Want You to Know
More than 5,700 women across Maryland will be diagnosed with breast cancer this year.
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
More than 5,700 women across Maryland will be diagnosed with breast cancer this year.
A proposal to lower the age at which most women begin receiving mammograms has the potential to save many lives,
Radiation therapy administered after lumpectomy or mastectomy has been shown to reduce the risk of breast cancer recurring, but the
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better
If you’re thinking you want to wait on that colorectal cancer screening recommended by your healthcare provider, two medical oncologists
Being at the top of your game isn’t easy. It takes countless hours of work, dedication, compassion and a drive
Bhavesh Balar, MD, says that a dramatic increase in cancer treatment options and the prolonged survival those regimens are providing
When the doctor’s office you enjoy visiting most is the clinic where you received chemotherapy, somebody there is doing something
Each year, more than 287,000 women and about 2,700 men in the United States are diagnosed with breast cancer. And
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.